Literature DB >> 1367518

Ambruticin S production in air-lift and stirred-tank bioreactors.

N W Hopf1, S Yonsel, W D Deckwer.   

Abstract

Using the method of equi-inocular synchronized comparative fermentation (EISCF) the cultivation of Sorangium cellulosum So ce 10 and production of the polyketide antibiotic ambruticin S was compared in stirred-tank and air-lift reactors of different geometry. This method requires that inocula originate from the same pre-culture and cultivation parameters are synchronized to similar values. Similar ambruticin yields were obtained from both reactor systems provided that the concentration of dissolved oxygen (DO) was maintained above a certain value (ca. 40%). For cultivation of S. cellulosum it is the DO level rather than the oxygen transfer rate which presents the proper criterion for scale-up and comparative reactor studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1367518     DOI: 10.1007/bf00170057

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  5 in total

1.  Ambruticin S production in amino acid rich media.

Authors:  N W Hopf; S Yonsel; W D Deckwer
Journal:  Appl Microbiol Biotechnol       Date:  1990-02       Impact factor: 4.813

2.  Ambruticin (W7783), a new antifungal antibiotic.

Authors:  S M Ringel; R C Greenough; S Roemer; D Connor; A L Gutt; B Blair; G Kanter
Journal:  J Antibiot (Tokyo)       Date:  1977-05       Impact factor: 2.649

3.  Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice.

Authors:  H B Levine; S M Ringel; J M Cobb
Journal:  Chest       Date:  1978-02       Impact factor: 9.410

4.  In vitro and in vivo studies of ambruticin (W7783): new class of antifungal antibiotics.

Authors:  S M Ringel
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Cultivation of E. coli in single- and ten-stage tower-loop reactors.

Authors:  I Adler; K Schügerl
Journal:  Biotechnol Bioeng       Date:  1983-02       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.